Monte Rosa TherapeuticsBoston, MA, United States
Director Non-Oncology Biology
0082: A VAV1-Directed Molecular Glue Degrader, MRT-6160, Reduces Joint Inflammation in a Collagen-Induced Arthritis Autoimmune Disease Model
Sunday, November 12, 20239:00 AM – 11:00 AM PT
Disclosure information not submitted.